B63. Immunocompromised Host Problems and Complications 2023
DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3902
|View full text |Cite
|
Sign up to set email alerts
|

A Routine Colonoscopy With an Unexpected Finding: Reactivation of Histoplasmosis in a Patient on Tocilizumab

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Histoplasma has been noted in individuals receiving immunosuppressive therapies such as methotrexate, prednisone, leflunomide, adalimumab, infliximab, and etanercept [8]. In addition, histoplasmosis has been seen in a patient receiving tocilizumab [9]. Over the years, our patient received immunosuppressive agents, which likely increased her susceptibility to this condition.…”
Section: Discussionmentioning
confidence: 75%
“…Histoplasma has been noted in individuals receiving immunosuppressive therapies such as methotrexate, prednisone, leflunomide, adalimumab, infliximab, and etanercept [8]. In addition, histoplasmosis has been seen in a patient receiving tocilizumab [9]. Over the years, our patient received immunosuppressive agents, which likely increased her susceptibility to this condition.…”
Section: Discussionmentioning
confidence: 75%